ALTHEA Gold Libraries Platform
Platform Development
N/AActive
Key Facts
About GlobalBio
GlobalBio is a private, pre-revenue biotech firm specializing in antibody discovery and engineering. Its core assets are the ALTHEA Gold Libraries™ platform for therapeutic antibody discovery and a proprietary humanization technology (GBM-Humanization™). The company operates through collaborations with pharmaceutical partners like Janssen and Tioma Therapeutics, positioning itself as a technology and service provider in the competitive antibody therapeutics space. Its strategic focus is on oncology, with early-stage programs targeting CD47.
View full company profileTherapeutic Areas
Other Platform Development Drugs
| Drug | Company | Phase |
|---|---|---|
| Precision Dosing Platform | Hikari Medical Technologies | Pre-clinical |
| Assay Automation | PathoFinder | Development |